Switzerland · 
Who invested in ImmunOs Therapeutics?
ImmunOs Therapeutics's investors include Lightspeed Venture Partners, European Union, Redalpine, Samsara BioCapital and Mission BioCapital.
Switzerland · Series C startup
Who invested in ImmunOs Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $11MSept 2024
- Investors
- 5
The rounds
- Sept 2024Series C$11M
Source recorded
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists ImmunOs Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ImmunOs Therapeutics
How much has ImmunOs Therapeutics raised?
ImmunOs Therapeutics has raised $11M across 1 round since 2024.
When did ImmunOs Therapeutics last raise?
ImmunOs Therapeutics's most recent round was a Series C of $11M in Sept 2024.
What was ImmunOs Therapeutics's biggest round?
Its most recent round, $11M in Sept 2024, is also its largest on record.
Who backed ImmunOs Therapeutics first?
ImmunOs Therapeutics's first round on record, in Sept 2024, was backed by Lightspeed Venture Partners, European Union and Redalpine and 2 others.
What stage is ImmunOs Therapeutics at?
ImmunOs Therapeutics's latest named round is a Series C, in Sept 2024.
Where is ImmunOs Therapeutics based?
ImmunOs Therapeutics is based in Switzerland.
Companies like ImmunOs Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.